CurrentCardio
Get Weekly

Topic · page 2 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 41–80 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. JACC Adv

    Absence of Fibrosis Influences Prognosis of Cardiac Resynchronization in Nonischemic Cardiomyopathy: Systematic Review and Meta-Analysis

    Meta-analysis

  2. Eur J Heart Fail

    Determinants and associations of health-related quality of life with mortality in acute and chronic heart failure: findings from the ESC HF III Registry

    Cohort study

  3. JACC Heart Fail

    Neurological Dysfunction During Contemporary Magnetically Levitated Left Ventricular Assist Device Support for Advanced Heart Failure: An STS-INTERMACS Analysis

    Cohort study

  4. Eur J Heart Fail

    Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement

    Guideline or statement

  5. JAMA Cardiol

    Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023

    Cross-sectional study

  6. JAMA Cardiol

    Cardiovascular-Kidney-Metabolic Overlap in Patients Hospitalized for Heart Failure

    Cohort study

  7. JAMA Cardiol

    Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka: A Randomized Clinical Trial

    Research article

  8. Eur Heart J

    Implementation of cardiac magnetic resonance imaging in everyday cardiology practice

    Guideline or statement

  9. ESC Heart Fail

    Finerenone versus spironolactone in heart failure with mildly reduced or preserved ejection fraction: a real-world study

    Cohort study

  10. Eur Heart J

    Acute cellular rejection after heart transplantation: validation of HEARTBiT, a transcriptomic biomarker

    Diagnostic or prognostic study

  11. ESC Heart Fail

    Cardiovascular outcomes with potassium binders in patients with heart failure and hyperkalaemia

    Cohort study

  12. JACC Cardiovasc Imaging

    Interaction Between Genotype, Phenotype, and Prognosis in Patients With Dilated Cardiomyopathy

    Cohort study

  13. ESC Heart Fail

    Proactive Heart Failure Screening in Obesity: Design, Recruitment and Baseline Characteristics of the SCORHFE Trial

    Trial design

  14. Am Heart J

    Efficacy of perioperative recombinant human brain natriuretic peptide for preventing acute kidney injury after cardiac surgery: Rationale, design, and study protocol for a multicenter, double-blind, randomized controlled trial (PROTECT-CS)

    Trial design

  15. Am Heart J

    Cardiac Remodeling, Prognostic markers, and Cardiovascular Outcomes Across Heart Failure Phenotypes in Adults with Congenital Heart Disease

    Research article

  16. JACC Adv

    Peripartum Cardiomyopathy Genetic Screening Protocol and Registry: The PERCVD Trial in the Gulf South

    Trial design

  17. Eur J Heart Fail

    Longitudinal proteomic organ-specific aging in heart failure

    Cohort study

  18. Heart Rhythm

    U-shaped Catheter Strategy for Percutaneous Endocardial Septal Radiofrequency Ablation in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Comparative Study

    Cohort study

  19. Heart Rhythm

    Sex differences in left bundle branch pacing for cardiac resynchronization therapy: novel procedural insights into pacing lead location

    Research article

  20. JACC Adv

    Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Pathway in High-Risk Lymphocytic Acute Myocarditis

    Research article

  21. JACC Cardiovasc Imaging

    Native T1 for Diagnosis and Risk Prediction in Amyloid Transthyretin Cardiomyopathy: An Observational Study on 1,675 Subjects

    Diagnostic or prognostic study

  22. JAMA Cardiol

    Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure: The FINEARTS-HF Randomized Clinical Trial

    Secondary analysis

  23. ESC Heart Fail

    Early versus delayed or no empagliflozin initiation after hospitalisation for heart failure in the United States: A target trial emulation

    Cohort study

  24. JACC Adv

    A Hemodynamic Echocardiographic Approach to Disease Severity and Prognosis in Transthyretin Amyloid Cardiomyopathy

    Research article

  25. Heart

    Sex differences in early ventricular fibrillation among patients with fulminant myocarditis in a nationwide registry

    Cohort study

  26. Circ Heart Fail

    Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection Fraction

    Diagnostic or prognostic study

  27. Circ Heart Fail

    Health-Related Quality of Life in Older Patients With Advanced Heart Failure From Before to 2 Years After Heart Transplantation or Long-Term Mechanical Circulatory Support: Findings From the SUSTAIN-IT Study

    Cohort study

  28. Circ Heart Fail

    Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv

    Cohort study

  29. ESC Heart Fail

    Inflammatory and catabolic activity mediate the association of plasma β-hydroxybutyrate and mortality in heart failure

    Cohort study

  30. JACC Adv

    The LEDA Score: An Integrated Echocardiographic Score for the Diagnosis of HFpEF

    Cohort study

  31. ESC Heart Fail

    Neutrophil-to-Lymphocyte Ratio in Patients With Heart Failure: Findings From The EMPEROR Program

    Secondary analysis

  32. JACC Adv

    Ventricular Strain Predicts the Risk of Right Heart Failure After Durable Left Ventricular Assist Device Implantation

    Cohort study

  33. JACC Heart Fail

    Genotype-Phenotype Associations in Pediatric Hypertrophic Cardiomyopathy: A Study From the Pediatric Cardiomyopathy Registry

    Cross-sectional study

  34. JACC Heart Fail

    Contemporary Trends in Outcomes After Heart Failure Hospitalization Among Medicare Beneficiaries

    Cohort study

  35. Eur J Heart Fail

    Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial

    Secondary analysis

  36. JACC Cardiovasc Imaging

    Myocardial Tissue Characterization by CMR Captures Mechanistic Severity Beyond Filling Pressure in HFpEF: The Multicenter DECIPHER HFpEF Study

    Cohort study

  37. ESC Heart Fail

    Prognostic Factors Associated with Fatal Outcomes in COVID-19 Vaccine-Related Myocarditis

    Cohort study

  38. Heart

    Discordance between N-terminal pro-B-type natriuretic peptide and left ventricular end-diastolic pressure in suspected heart failure with a preserved ejection fraction: implications for diagnosis and prognosis

    Cohort study

  39. ESC Heart Fail

    Exercise Training for Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Bayesian Network Meta-Analysis

    Meta-analysis

  40. ESC Heart Fail

    Linking Coronary Microvascular Dysfunction to Cardiac Troponin Elevation in Transthyretin Amyloid Cardiomyopathy

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 41–80 of 1,928, newest first